glp 1 and ibs is not just a sensitivity issue—it’s an inflammatory condition., For many patients, GLP-1 medications do more than support weight loss. They address one of the root drivers of IBS: inflammation in The Interplay Between GLP-1-Based Therapies,

Insureds need to be prepared to provide detailed answers to underwriters queries and meet with them in person where appropriate

Women may experience more variable results month to month due to hormonal fluctuations across the menstrual cycle

KLOW at a Glance Who Benefits Most from KLOW In my experience, KLOW is the right call for three distinct groups: The autoimmune / histamine-prone: those with high food intolerances, MCAS, or autoimmune conditions who experience high systemic inflammation

(2) studies that reported specific outcomes related to lipid profiles, including total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL)

Signaling via pancreatic -cells underlies the insulinotropic effects of GLP-1 RAs, while activation of enteric GLP-1Rs delays gastric emptying, effectively blunting postprandial glucose spikes and prolonging satiety (Kreymann et al., 1987